EASD 2017: ACE: Acarbose Did Not Improve Cardiovascular Outcomes in Patients With CHD and Impaired Glucose Tolerance
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Only registered members have full access to PracticeUpdate content.